Form 4 for NOC Northrop Grumman
Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0001628280-22-003044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-17 | 2022-02-16 | NOC | Petryszyn Mary D | Pres, CVP, Defense Systems | S - Sale+OE | $384.99 | -168 | 7,909 | -2% | -$64.7K |
| D | 2022-02-17 | 2022-02-15 | NOC | Petryszyn Mary D | Pres, CVP, Defense Systems | F - Tax | $384.77 | -541 | 8,077 | -6% | -$208.2K |
| D | 2022-02-17 | 2022-02-15 | NOC | Petryszyn Mary D | Pres, CVP, Defense Systems | M - OptEx | $0.00 | +1,795 | 8,618 | +26% | $0 |
| DM | 2022-02-17 | 2022-02-15 | NOC | Petryszyn Mary D | Pres, CVP, Defense Systems | A - Grant | $0.00 | +8,497 | 20.4K | +71% | $0 |
| D | 2022-02-17 | 2022-02-15 | NOC | Petryszyn Mary D | Pres, CVP, Defense Systems | M - OptEx | $0.00 | -1,795 | 18.6K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-16 | S | D | 168 | $384.99 | 7,909.30 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
| 2 | Common | Common Stock | 2022-02-15 | F | D | 541 | $384.77 | 8,077.30 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-15 | M | A | 1,795 | $0.00 | 8,618.30 | D | — | — | |
| 4 | Derivative | Restricted Stock Rights | 2022-02-15 | A | A | 2,457 | $0.00 | 8,286 | D | — · — to — | 2,457 Common Stock | (F2) Each Restricted Stock Right ("RSR") represents a contingent right to receive an equivalent number of shares in Issuer common stock, or, at the election of the Issuer's Compensation Committee, cash or a combination of cash and Issuer common stock. The RSRs were granted under the Long-Term Incentive Stock Plan ("LTISP") on 2/15/22 and will vest on 2/18/25. |
| 5 | Derivative | Restricted Performance Stock Rights | 2022-02-15 | M | D | 1,795 | $0.00 | 18,613 | D | — · — to — | 1,795 Common Stock | (F3) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |
| 6 | Derivative | Restricted Performance Stock Rights | 2022-02-15 | A | A | 6,040 | $0.00 | 20,408 | D | — · — to — | 6,040 Common Stock | (F4) The RPSRs acquired include (i) 659 vested RPSRs with respect to the measurement period ended 12/31/21 acquired due to settlement of the RPSRs granted under the 2011 Long-Term Incentive Stock Plan ("LTISP") on 2/13/19 that resulted in settlement at 158% of the target award; and (ii) 5,381 unvested RPSRs granted under the LTISP on 2/15/22 with a measurement period ending on 12/31/24. A total of 1,795 shares were issued in settlement of the 2019 RPSRs with a measurement period that ended 12/31/21, and the target award amount of 1,136 RPSRs was previously reported in connection with the grant of the 2019 RPSRs. (F3) Each Restricted Performance Stock Right ("RPSR") represents a contingent right to receive an equivalent number of shares of Issuer common stock, or, at the Issuer's election, cash or a combination of cash and Issuer common stock. The RPSRs vest if the applicable performance metric is satisfied for the relevant measurement period. Grants awarded pursuant to Rule 16b-3(d). |